Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 16/20 | 0.90 |
| ▸ | CA2 | P00918 | 16/20 | 0.90 |
| ▸ | CA12 | O43570 | 12/20 | 0.90 |
| ▸ | CA9 | Q16790 | 12/20 | 0.90 |
| ▸ | CA4 | P22748 | 7/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8071471 | 0.90 | CA1 (0.90) | CA1CA2CA12CA9CA4 | |
| SCHEMBL8071460 | 0.90 | CA1 (0.90) | CA1CA2CA12CA9CA4 | |
| SCHEMBL21768241 | 0.88 | CA1 (0.77) | CA1CA2CA12CA9CA4 | |
| SCHEMBL23922195 | 0.87 | CA1 (0.68) | CA1CA2CA12CA9CA4 | |
| SCHEMBL15148345 | 0.86 | CA1 (0.82) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2282260 | 0.86 | CA1 (0.88) | CA1CA2CA12CA9CA4 | |
| SCHEMBL594922 | 0.85 | CA1 (0.74) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2281606 | 0.83 | CA1 (0.77) | CA1CA2CA12CA9CA4 | |
| SCHEMBL20788644 | 0.80 | CA1 (0.76) | CA1CA2CA12CA9CA4 | |
| SCHEMBL2282319 | 0.80 | CA1 (0.70) | CA1CA2CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11147890-B2 | Stimuli-responsive particles encapsulating a gas and methods of use | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2021-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11147890-B2 | Stimuli-responsive particles encapsulating a gas and methods of use | CGAS, GRPR, CLPX | CA1 644/4885CA2 591/4885CA12 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.